IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 8 analysts with an average price target of $40.07. This is a potential upside of $13.65 (51.67%) from yesterday's end of day stock price of $26.42.

Immunovant 's activity chart (see below) currently has 145 price targets and 114 ratings on display. The stock rating distribution of IMVT is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.27% with an average time for these price targets to be met of 179.17 days.

Highest price target for IMVT is $61, Lowest price target is $16, average price target is $33.86.

Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 14-Oct-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$16

$-8.15 (-33.75%)

$36

1 months 29 days ago
(14-Oct-2025)

2/4 (50%)

$-1.49 (-8.52%)

35

Buy

$33

$8.85 (36.65%)

$37

2 months 13 days ago
(30-Sep-2025)

0/4 (0%)

$16.88 (104.71%)

Buy

$35

$10.85 (44.93%)

$51

3 months 9 days ago
(04-Sep-2025)

11/21 (52.38%)

$18.88 (117.12%)

268

Buy

$30

$5.85 (24.22%)

$33

4 months 1 days ago
(12-Aug-2025)

1/4 (25%)

$14.79 (97.24%)

126

Hold

$17

$-7.15 (-29.61%)

$41

7 months 21 days ago
(22-Apr-2025)

2/6 (33.33%)

$2.75 (19.30%)

41

Show more analysts

Please expand the browser size to see the chart

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.17 days on average for the stock forecasts to be realized with a an average price target met ratio 59.27

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 0 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Alex Thompson with highest potential upside - $36.85

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$17.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?